Activated killer monocytes and tumoricidal activity and pharmace

Details Activated killer monocytes and tumoricidal activity and pharmace Activated killer monocytes and tumoricidal activity and pharmace

1994-04-22

1996-04-30

Wityshyn, Michael G.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving viable micro-organism

424 854, 424 855, C12Q 102, A61K 3766

Patent

active

055124534

ABSTRACT:
The present invention discloses substantially pure, functional, human, clinical grade, activated killer monocytes (AKM) produced in suspension in polypropylene ware in a serum-free medium and a pharmaceutical composition for immunotherapy of humans, comprising an immonotherapeutic amount of the AKM of the present invention and a sterile pharmaceutically acceptable carrier.

REFERENCES:
patent: 4849509 (1989-07-01), Thurin
patent: 5053216 (1991-10-01), Ehrenfeld
patent: 5093115 (1992-03-01), Stevenson
Stevenson H. C., The Potential Value of Cytapheresis . . . Plasma Ther Transfus Technol 1984 5 pp. 237-250.

Affiliated with

Also associated with

Rating

Activated killer monocytes and tumoricidal activity and pharmace does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Activated killer monocytes and tumoricidal activity and pharmace, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activated killer monocytes and tumoricidal activity and pharmace will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-627843